4.6 Article

Establishing an hTERT-driven immortalized umbilical cord-derived mesenchymal stem cell line and its therapeutic application in mice with liver failure

Journal

JOURNAL OF TISSUE ENGINEERING
Volume 14, Issue -, Pages -

Publisher

SAGE PUBLICATIONS INC
DOI: 10.1177/20417314231200328

Keywords

Umbilical cord mesenchymal stem cell; telomerase; TERT; immortalization; acute liver failure; treatment

Ask authors/readers for more resources

Acute liver failure (ALF) is a severe disease with high mortality, but therapy using mesenchymal stem cells (MSCs) or MSCs-derived exosomes has shown promise in animal experiments and clinical application. To address limitations of MSCs, an immortalized MSC cell line called hTERT-UCMSC was constructed and shown to retain key characteristics over long-term culture. Inoculation of hTERT-UCMSC and its exosomes improved the survival rate and liver function in ALF mice, suggesting their potential use in clinical treatment of liver failure.
Acute liver failure (ALF) is characterized by rapid liver cell destruction. It is a multi-etiological and fulminant complication with a clinical mortality of over 80%. Therapy using mesenchymal stem cells (MSCs) or MSCs-derived exosomes can alleviate acute liver injury, which has been demonstrated in animal experiments and clinical application. However, similar to other stem cells, different cell sources, poor stability, cell senescence and other factors limit the clinical application of MSCs. To achieve mass production and quality control on stem cells and their exosomes, transfecting umbilical cord mesenchymal stem cell (UCMSC) with lentivirus overexpressing human telomerase reverse transcriptase (hTERT) gene, the hTERT-UCMSC was constructed as an immortalized MSC cell line. Compared with the primary UCMSC (P3) and immortalized cell line hTERT-UCMSC at early passage (P10), the hTERT-UCMSC retained the key morphological and physiological characteristics of UCMSC at the 35th passage (P35), and showed no signs of carcinogenicity and toxic effect in mice. There was no difference in either exosome production or characteristics of exosomes among cultures from P3 primary cells, P10 and P35 immortalized hTERT-UCMSCs. Inoculation of either hTERT-UCMSC (P35) or its exosomes improved the survival rate and liver function of ALF mice induced by thioacetamide (TAA). Our findings suggest that this immortalized cell line can maintain its characteristics in long-term culture. Inoculation of hTERT-UCMSC and its exosomes could potentially be used in clinics for the treatment of liver failure in the future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available